Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,598 | -16,703 | -10,947 | -8,064 |
| Depreciation Amortization | 136 | 589 | 447 | 303 |
| Accounts receivable | N/A | N/A | N/A | -3,000 |
| Accounts payable and accrued liabilities | 385 | N/A | 1,924 | 1,662 |
| Other Working Capital | 678 | 1,044 | 2,828 | -514 |
| Other Operating Activity | 351 | 110 | -2,512 | 683 |
| Operating Cash Flow | $-4,048 | $-14,960 | $-8,260 | $-8,930 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -99 | -1,200 | -944 | -944 |
| Investing Cash Flow | $-99 | $-1,200 | $-944 | $-944 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | N/A | N/A | 2,781 | N/A |
| Debt Issued | N/A | N/A | 1,254 | 1,254 |
| Common Stock Issued | 13 | N/A | N/A | N/A |
| Other Financing Activity | 7,738 | 72,682 | 0 | 0 |
| Financing Cash Flow | $7,751 | $72,682 | $4,035 | $1,254 |
| Beginning Cash Position | 73,058 | 16,536 | 16,536 | 16,536 |
| End Cash Position | 76,662 | 73,058 | 11,367 | 7,916 |
| Net Cash Flow | $3,604 | $56,522 | $-5,169 | $-8,620 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,048 | -14,960 | -8,260 | -8,930 |
| Capital Expenditure | -99 | N/A | -944 | -944 |
| Free Cash Flow | -4,147 | -14,960 | -9,204 | -9,874 |